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ABSTRACT 
In India, according to WHO 2018 statistics, there were 63% of death occurred due to Non-communicable diseases (NCDs), in which Cardiovascular 
diseases were leading cause of death 27%, followed by Cancer 9%, Chronic respiratory disease 11%, Diabetes 3% and other NCDs 13%. This 
indicates that NCDs needs to become a priority in controlling and preventing. Therefore, the only effective intervention may be at controlling and 
preventing NCDs disease is Integrative Medicine. Integrative Medicine is a medical practice synthesizing Traditional medicine and Biomedicine 
preventive measures and treatment interventions. Autonomy of patients may end in no benefit out of their ignorance to select between the 
treatment options available in a country like India where Seven Recognized medical systems are available as a platter. Siddha system of medicine is 
one of the traditional medicines of India, practiced in the southern part of the country. This study aims at providing Health care system under one 
roof, in order to save public money, time and health as an existing model as co-location in Tamil Nadu. This can be achieved through assessing 
feasible areas of integration in the Siddha system of medicine with biomedicine. So the study deals with the utilization of Siddha system of medicine, 
scientific validation of Siddha medicines, Siddha medicine research undertaken by biomedical practitioners and some government policies 
supporting mainstreaming of Siddha.  
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INTRODUCTION 
Definition of integrative medicine (IM) is healing-
oriented medicine that takes account of the whole person, including all 
aspects of lifestyle. It emphasizes the therapeutic relationship between 
practitioner and patient, is informed by evidence and makes use of all 
appropriate therapies [1]. Based on the review and close reading of 
medical peer-reviewed journals and government health statistics, Null 
et al. [2] show that the number of people having In-hospital, adverse 
drug reactions (ADR) to prescribed medicine in the US is 2.2 million 
per year. The most stunning statistic, however, is that the total number 
of deaths caused by conventional biomedicine is 783,936 per year, far 
higher than the number of deaths attributable to heart disease in 2001 
that was 699,697 and cancer that was 553,251. In India, neither do we 
have any statistics of damages caused by medicine, nor a procedure to 
record damages due to medical errors and iatrogenic effects. The 
increase in the prevalence of non-communicable diseases, drug 
resistance and pharmaceutical complications; growing dissatisfaction 
with the outcomes of certain biomedical treatments; and the gaps 
provide conventional health care to several segments of the 
population, have directed much attention to traditional, 
complementary and alternative medical (TCAM) systems [3]. This has 
led global population to conceive the idea of integration of 
Biomedicine with Traditional Medicine as it may mutually benefit both 
the medical systems in the form of filling up the gaps.  
Indian traditional medicine is prevalent around the globe and 
integration exists scatterdly with modern medicine for different 
health needs [4]. Siddha system of medicine is one of the traditional 
medicines of India, practiced in the southern part of the country. It is 
a primordial system of medicine that existed in the world. Siddhars 
are the spiritual scientists; they are well versed in Metallurgy, 
Geology and Phytochemistry. They have used all kinds of herbs, 
metals, minerals and animal products vastly. In spite of their 
popularity, the rational design, proper standardization, and careful 
monitoring of traditional Indian formulations, along with tough 
scientific evidence, are essential for their promotion [4]. In our time, 
there are lots of research are undertaken to bring out the scientific 
validation of Siddha medicine and they are published in national and 
international peer-reviewed journals. In AYUSH research portal 
around 1153 Siddha research articles, some of the research articles 
for various diseases are listed below (table 1). 
 
Table 1: Some important clinical trials, pre-clinical trials done in Siddha system of medicine (scientific evidence) 
First author/year Diseases Study type/Sample size Siddha Intervention References 
Carlo Calabrese/2008  
 
Cognitive performance, 
Anxiety, Depression  
Randomized, Double-Blind, 
Placebo-Controlled Trial (48) 






randomized, phase IV clinical 
trial (95) 
Madhumega choornam (Internal) [6] 
G. S. Lekha/2018  Dengue  Cohort study (100) Nilavembu Kudineer (Internal) [7] 
Arul Mozhi P/2016  Cerebral palsy  Phase II Clinical trial (210) Brahmi nei (Internal) [8] 
Sugunthan s/2017  Cervical spondylosis  Phase II Clinical trial(60) Vilvaver kudineer (Internal), 
Varmam (Physical manipulation) 
[9] 
 




Rajalakshmi S/2019  Psoriasis  
 
Open, Comparative clinical trial 
(40) 
Panchamuga chendhuram (Internal) 
Kundavaathi thailam (External oil) 
[11] 
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Phase II Clinical trial (40) Perumbadukku pittu (Internal) 
 
[12] 
Karthik nagarajan  Male infertility  Open, Comparative Clinical trial 
(40) 








Phase II Clinical trial (30) Suttigai (Cauterization) 
 
[14] 




Siva josyaa s/2018  Urticaria  
 
Phase II Clinical trial 
(20) 
Nilavagai Chooranam (Internal) 
Sanjeevi Thylam (External) 
[16] 
 
Bapat RD/1998  Varicose ulcer Phase II Clinical trial (20) Attai vidal (Leech therapy) [17] 
G. Ridhambaradevi/2018  Cerebral palsy 
 
Phase II Clinical trial (10) 
 
Brahmi nei (Internal medicine) 
Podithimirthal (Dry powder 
massage) 
[18] 
P. Mirunaleni/2018  Diabetes  Phase II Clinical trial (10) Yoga therapy [19] 
K. Samraj/2017  Benign Prostate 
Hypertrophy  
Case series (10) Velvanga parpam (Internal) 
 
[20] 
R. Gayatri/2019 Renal calculi  Case series (2) Nilavembu Kudineer (Internal) [21] 
Natrajan/2019  Acute avulsion of 
posterior cruciate 
ligament of knee with 
bone fragment 
Case study Varmam (Physical manipulation) [22] 
Lalitha sivasankaran/2019  Tennis elbow  Case study Attai vidal (Leech therapy) [23] 
L. Janani/2018  Insomnia   Case report Varmam (Physical manipulation) [24] 
G. S. Lekha/2018  Tinea infection  Case study Sivanaramritham (Internal) 
Thriphala chooranam (Internal) 
Karbogi paste (External) 
[25] 
 
Sivakkumar S/2018  Varicose ulcer Case study Pugai (Fumigation)  [26] 
Aruna devi R/2018  Diabetic Ulcer Preclinical study Matthan thailam (External) [27] 
Kumaravel Appavoo/2019  Peptic ulcer  Preclinical study Sirucinni Uppu (Internal) [28] 
ChristianGJ/2014  Peptic ulcer  Preclinical study Anda leghyam (Internal) [29] 




Review Varmam (Physical manipulation) [30] 
S. Bhavani/2017  Hepatitis-B  Review Internal medicine [31] 
Dharani/2016 M  Hemorrhoids  Review Pugai (Fumigation)  [32] 
Chitra, Beyaril/2015  Senile Dementia  Review Internal medicine [33] 







Internal medicine [35] 
Jeeva gladys. R/2013 Oncology Review Internal medicine [36] 
 
Table 2: Utilization of siddha system of medicines in siddha OPDs around Tamil Nadu 
1st Author Sample size 
Male/Female n (%) 
Place/Duration of the study Morbidities n (%) References 
Kanna et al.  1511 
Male 1070 (73) 
Female 411 (27) 
 
Special 
Geriatric Clinic, Siddha 























Selva Raj k et 
al. 
763 
Male 445 (58.3) 
Female 318(41.7) 
 
2 Siddha OPD (Andhiyur and 
Bhavani Government 
Hospitals), Erode District, 























M M Reddy et 
al. 
227 
Males 138 (60.8) 
Female 89 (39.2) 
2 Siddha OPD (Andhiyur and 
Bhavani Government 
Hospitals), Erode District, 














Male 807 (46.9) 
Female 913 (53.1) 
2 Siddha OPD, (Andhiyur and 
Bhavani Government 
Hospitals), Erode District, 
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Utilization of siddha system of medicines 
In a study Shalini Rudra et al. explore the out-of-pocket expenditure on 
AYUSH treatment. The result shows that, the average expenditure on 
AYUSH medicines is Rs 270 in rural and Rs 378 in urban areas and is 
lower than average expenditure on non-AYUSH (allopathic) medicine 
[37]. This study focuses on AYUSH and lacks individual System wise 
which is warranted. To explore the integrative medicine, it is vital to 
understand the feasibility, efficacy and acceptability of Siddha 
interventions among the public. Some of the studies in Siddha OPDS 
around Tamil Nadu are listed below (table 2). The common use of 
Siddha medicines is for skin diseases, musculoskeletal disorder, 
diabetes, Respiratory diseases, gastrointestinal diseases. 
Various siddha medicine research conducted by biomedicine 
practitioners  
1. Thanikachalam et al., conducted a study to evaluate the clinical 
efficacy and safety of the polyherbal compound MMC in the 
management of type 2 diabetes. This pilot study was an open, non-
comparative, non-randomized, phase IV clinical trial, conducted at 
the PURSE-HIS research station, at Sri Ramachandra University, 
Porur, Chennai, India from January 2008-2010. The trial included 95 
patients; the results revealed that the fasting, postprandial blood 
glucose, HbA1c showed significant reduction after MMC 
intervention. The liver, renal functions, along with the hematological 
parameters were well within the normal range[6]. 
2. Govindan et al. conducted a study on the clinical efficacy of 
Solanum xanthocarpum and Solanum trilobatum in bronchial asthma 
at Madras medical college; the results revealed that improvement in 
Peak expiratory Flow rate (PEFR) and the reduction in other symptom 
scores clearly show a bronchodilator effect, a decrease of edema and 
secretions in the airway lumen. The response to these herbs, equal to 
that of deriphylline but less than salbutamol [42].  
3. P. M. Murali et al., conducted a randomized, double-blind study 
with Plant-based formulation (DCBT1234-Lung KR) in the 
management of chronic obstructive pulmonary disease, result 
revealed that, Improved PaO2 was observed in 15.4% of DCBT1234-
Lung KR patients while no improvement was seen with patients in 
any other arms. Symptoms like dyspnoea, wheezing, cough, 
expectoration, disability and sleep disturbances also considerably 
reduced in DCBT1234-Lung KR and the biomedical group patients, 
but not in the placebo arm. DCBT1234-Lung KR was alike, but not 
better than the present-day treatment with salbutamol, theophylline 
and bromhexine combination in COPD patients and this was 
ascertained using FEV1 and ABG values [43]. 
4. P. M. Murali et al., conducted a controlled clinical trial to 
compare plant-based formulation (DCBT4567-Astha-15) efficacy 
with oral salbutamol and theophylline for Bronchial Asthma, the 
results revealed that DCBT4567-Astha-15 was as efficacious as 
salbutamol (12 mg/day) in combination with theophylline (200 
mg/day) treat reversible asthmatics. Quality of life of patients also 
improved with DCBT4567-Astha-15 drug treatment [44].  
5. Chidambaram s. babu et al., conducted a trial on Venthamarai 
chooranam, a polyherbal Siddha medicine, alleviates hypertension 
via AT (1)R and eNOS signaling pathway in 2K1C hypertensive rats, 
2014 in Ramachandra University, Porur, Chennai, India. The result 
shows, Venthamarai chooranam potentially interacts with renin-
angiotensin components and endothelial functions, and 
antihypertensive action[45].  
6. Chidambaram s. babu et al., conducted a study on Polyphenols in 
madhumega chooranam, a Siddha medicine, ameliorates 
carbohydrate metabolism and oxidative stress in type II diabetic rats 
in Ramachandra University, Porur, Chennai, India. The results 
revealed that Madhumega chooranam mediates its anti-diabetic 
action through the inhibition of gluconeogenesis and activation of 
glycolytic pathways in type II diabetic rats. Increased GLUT4 and 
PPARγ expressions provide more information on its glucose 
uptake/sensitising and hypolipidemic potential [46]. 
7. KR Subash et al. conducted the study in Sri venkateshwara 
institute of medical science, tirupati, Andhra Pradesh, India. They 
evaluated the analgesic activity of Alpinia galanga extract in mice 
models and TNF-alpha receptor computational docking analysis on 
its leads with pharmacokinetics prediction. The results showed 
Alpinia galanga extract had significant antinociceptive activity and 
followed by computational analysis of 20 compounds with known 
chemical structure predicted Galanal B as a lead compound with 
best in-silico pharmacokinetic and drug-like features [47]. 
8. R. V. Ramanarayana Reddy et al. conducted the study at 
Melmaruvathur Adhiparasakthi Institute of Medical Sciences and 
Research, Tamil nadu, India. Evaluation of the antidiabetic activity of 
polyherbal formulation of Seenthil churnam in Alloxan induced 
diabetic rats. Administration of alcohol extract of Seenthil Churnam 
produced a dose-dependent decrease in blood glucose levels in 
Alloxan induced rats. There was a significant fall in blood sugar level 
in the dose of 300 mg/kg; this is comparable to the effect of 
Glibenclamide [48]. 
9. Thyagarajan SP et al. conducted a trial in CMC Hospital, vellore, 
India. 24 healthy long-term HBV carriers were treated with 
phyllanthus amarus and placebo; the result shows HBsAg clearance 
and HBV-DNA levels were significantly reduced [49]. 
10. J. Saikarthik et al. conducted the trial in Saveetha medical college 
and hospital, Chennai, Tamilnadu, India. Phytochemical analysis of 
methanolic extract of seeds of Mucuna pruriens by gas 
chromatography-mass spectrometry; the analysis reveals the 
presence of 5 major compounds namely, pentadecanoic acid, 14-
methyl-, methyl ester, dodecanoic acid, 9,12-octadecadienoic acid 
(z,z)-, methyl ester, 9,12-octadecadienoic acid and 2-myristynoyl-
glycinamide which are therapeutically potential [50]. 
These examples show how the benefits of Siddha medicines could be 
brought into the mainstream health care where they are balanced to 
play an increasingly important role. 
Government health policies for mainstreaming of siddha 
Several policies which may help to integrate Siddha medicine for 
health care system are listed below, 
1. Udupa Committee in its report published in 1958 recommended 
that there is a need for integrated system of medicine in India [51]. 
2. The National Population Policy 2000, National Health Policy 
2002, and the National Commission on Macroeconomic and 
Health—2005 of the Ministry of Health and Family Welfare, 
Government of India, emphasized on reorientation and 
prioritization of research in Ayurveda, Yoga and Naturopathy, Unani, 
Siddha and Homoeopathy (AYUSH) and to confirm therapy and 
drugs in chronic and lifestyle-related diseases [52,53]. 
3. The National Health Policy (NHP) 2017 has strongly advocated 
mainstreaming the potential of AYUSH within a pluralistic system of 
Integrative health care. The NHP 2017 uses a new language of 
‘medical pluralism’ and re-emphasizes the need for integrating 
AYUSH in the National Health Mission, research and education. 
Indeed, the NHP 2017 is the most powerful policy expression of 
integrative healthcare since independence for which the Ministry of 
Health and Family Welfare must be congratulated. NHP 2017 
highlights strategies to meet national health goals through protocol 
driven integrative practices [54]. 
4. Ministry of AYUSH, along with Directorate General of Health 
Services (DGHS) is implemented NPCDCS (National Programme for 
Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases 
and Stroke) for health promotion, prevention and management of 
Noncommunicable diseases or Lifestyle related disorders [55]. 
5. Nilavembu kudineer 
At the time of dengue epidemic 2012, the Tamil Nadu government 
distributed a Siddha herbal decoction, Nilavembu kudineer (NVK) at 
free of cost. Health and Family Welfare Department letter No. 
41459/IM1(2)/2012, dated 21.11.2012 stated that “Nilavembu 
decoction, traditional Siddha drug is effective in the treatment of 
viral fevers like dengue”. The Nilavembu kudineer has 9 ingredients 
they are Nilavembu (Andrographis paniculata), Vilamichai Ver 
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(Plectranthus vettiveroides), vetiver (Vetiveria zizanioides), Cukku 
(Zingiber officinale), Milagu (Piper nigrum), Korai kizhangu (Cyperus 
rotundus), Santanam (Trichosanthes cucumerina), Parpadagam 
(Mollugo cerviana). This is not only to treat diseases, but also to 
prevent diseases [56]. As a result, there is a reduction in morbidity 
and mortality of dengue fever. The antiviral activity of nilavembu 
kudineer was estimated by Jaspreet jain et al. [57], dengue and 
chikungunya virus through in vitro evaluation shows, NVK provides 
protection against CHIKV and DENV-2 during active infection and 
also help to prevent virus infection in the cells.  
6. Amma magapeeru sanjeev kit 
For the first time, drugs of Siddha systems have been incorporated 
into the kits of ante-natal cases throughout the state of Tamilnadu. 
Health and Family Welfare Department Demand No.19 Policy Note 
2016-17 stated that Amma maperu sanjeevi, at Rs. 10 crore scheme, 
which will have a bouquet of 11 siddha medicines for pregnant 
women and newborn.” A kit contains Madhulai Manappagu, 
Karuveppilai Podi, Nellikkai Legiyam, Elathy tablet, Annabedhi 
tablet, Ulundhu thailam and Pinda Thailam (both for external 
application), Paavana Panchakula thailam, sathavari legium, 
kunthiriga thailam, Urai mathirai. These medicines will reduce 
nausea, vomiting, balancing iron deficiency, reducing false pain, 
improve immunity in infants. This helps the health systems to take 
care of many of women and children as a first line of care through 
the Siddha medicine [58]. 
Areas of focus in integration 
Varmam (Physical manipulation) 
In biomedicine, the treatment for musculoskeletal disorders are 
local injections of steroids, Nonsteroidal anti-inflammatory drugs 
(NSAIDs), opioids, antidepressants, muscle relaxants are either 
ineffective or provide short-lasting benefits [59]. With this hitch the 
medical industry is in need of effective, long lasting benefits in 
musculoskeletal disorders. Siddha varmam therapy originated from 
the southern part of Tamilnadu, is now practiced in South Asian 
countries like India, Srilanka and Malaysia. Varmam specifies the 
therapeutic manipulation of certain points in which the life energy is 
found pooled. Handling on these points with a particular force for 
the definite time will release the life energy from these points and 
fetch relief to the affected individual by regulating the flow of life 
energy which is blocked due to attack on particular Varmam points 
or due to other causes [22]. It offers a conservative management 
approach to pain, Neuro-musculoskeletal disorders, metabolic 
disorders, sensory defects, gastrointestinal, respiratory diseases, 
endocrine disorders, pediatric diseases like autism and trauma 
[9,22,24,30]. The advantages of varmam are non-invasive technique, 
cost effective, easy to manipulate. Siddha varmam therapy may open 
new perspectives in the area of pain management. A national 
Guidelines to Practice varmam is available in India published by 
CCRS (Central Council for research in Siddha), Ministry of AYUSH, 
Government of India [60]. 
Karanool sigichai (Chemical cauterization) 
Karanool sigichai is a unique para surgical treatment carried out for 
the management of fistula-in-ano. It is a method of chemical 
cauterization of fistula. Achyranthus salt, Dalmia extensa salt etc. are 
smeared on a surgical thread which is used to cut the tract. The 
major advantages of this procedure are, it will preserve the function 
of continence and prevents the recurrence of the condition and also 
cost effective [61,62]. This will open up a new scope of Siddha para-
surgical procedure in Anal fistula. 
Attai vidal (Leech therapy) 
In the Act of June 28, 2004, the Food and Drug administration (FDA) 
cleared for the first time the commercial marketing of medicinal 
leeches for medicinal purposes and determined that leeches are 
medical devices. In Siddha text leech therapy, especially indicated 
for edema, headache, abdominal pain caused by dysentery, 
whooping cough in children, inflammatory joint diseases, eye 
diseases. Bio-constituents in leech saliva have vasodilator, 
anesthetic, anti-inflammatory activity and also inhibits the blood 
coagulation [63]. Leech therapy is used clinically for various 
diseases they are Osteoarthritis, Epicondylitis, varicose veins, and 
hematoma. It is also evident leech was used in dreadful condition, 
menigococcal purpura. As an integrative approach now leech is used 
in bone reconstruction surgery.  
Yoga 
The term ‘Yogam’ means ‘union’. Siddhars have defined yogam as an 
art which controls the mind by preventing it from distracting 
through sense and sense organs and fuse it with the divinity. The 
eight steps or stages of yogam areIyamam (Learning discipline), 
Niyamam (Purity of action), Asanam (posture), Pranayamam 
(controlling one’s breath), Prathyaharam (Controlling 5 senses), 
Dharanai (the practice of concentration), Dhyanam and Samadhi. 
Third step or stage of yogam is asanam, means posture or pose, it is 
also called as yogasanam. The perfect and scientific art of controlling 
one’s breathing is called Pranayamam. It is also called as ‘vasi’ and 
‘vasiyogam [64]. Yoga can be integrated with various diseases such 
as Musculoskeletal disorders, Bronchial asthma [65], hypertension 
[66], depression, insomnia etc [13,19]. It can also be used as an 
adjuvant therapy for many non-communicable diseases. 
DISCUSSION  
The concept of ‘integrative’ medicine has come up several times 
earlier and is not new. This, however is not a call for Siddha alone, 
but it is all about the direction of change. World Health Organization 
(WHO) has announced desirable doctor–population ratio as 1:1,000. 
In India as per current population, it gives a doctor (modern 
medicine) and a population ratio of 0.77:1,000 [65]. After 
considering AYUSH registered medical practitioners it counts, 1.33 
billion of Indian population is being served by 1.8 million registered 
medical graduates during 2017. So, the ratio is 1.34 doctor for 1,000 
Indian citizens as of 2017. This shows that India reached WHO norm 
by 1:1,000 doctor population ratio after considering AYUSH doctors. 
Besides this an assessment of the mainstreaming of AYUSH in 
Rajasthan, India [Society for Economic Development and 
Environmental Management (SEDEM) n. d.], revealed that AYUSH is 
popular and regularly accessed by the community. Approximately 
half the allopathic doctors studied reported never referring patients 
to AYUSH doctors3 the lack of knowledge about traditional medicine 
in biomedicine practitioner is the reason behind this crisis; this can 
be rectified by including traditional medicine in the MBBS 
curriculum itself.  
The Indian government also supports to promote the traditional 
medicine in India. The budget al. location for the Dept of AYUSH has 
increased gradually over the years. In the 12th Five Year Plan of 
India (2012–2017), the total allocation for AYUSH was INR. 10,044 
crore, which was 235% more than the actual expenditure of 11th 
Plan [66]. Till date, AYUSH facilities have been co-located in 506 
District Hospitals, 374 sub district Hospitals, 2871 CHCs, 8995 PHCs, 
and 5716 other healthcare centers. The Magnitude of AYUSH 
infrastructure in the country has reached 7,99,879 registered 
practitioners, said by the AYUSH minister on 19 July 2019 [67, 68]. 
Although we have proof of scientific validation, the utilization of 
Siddha medicines for various diseases, the data for Siddha 
Intervention as Add-on, limitations for Siddha intervention 
(Dislodgement of renal calculi of bigger size), areas where Siddha 
can compliment such as usage of Mathan thylam in diabetic ulcer 
without disturbing the contemporary treatment module, drug-drug 
interactions, drug food interactions and food based health benefits 
have to be documented. The discovery of complete integrative 
approach guidelines of Siddha medicine with biomedicine is the only 
approach to resolve this crisis. Both Siddha and biomedicine experts 
in a particular field should assemble and prepare the guideline to 
safeguard the public.  
CONCLUSION 
Hence, there has been a huge utilization of Siddha medicine and also 
proof of scientific validation of Siddha medicine its usage in both 
communicable and non-communicable diseases, Integrating Siddha 
medicine with biomedicine is essential to offer better health 
facilities to public. Integration of Siddha with the existing health care 
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system, not only helps in preventive and promotive health also 
focuses more in complementing Biomedicine by offering profound 
Siddha Varmam, Yoga therapy. Integrative approach is the only way 
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